Clinical snapshot — for veterinary teams
- Active ingredient / class: afoxolaner — isoxazoline
- Indication: flea and tick treatment/prevention in dogs; prevention of Lyme via tick kill; covers black-legged, American dog, brown dog, and lone star ticks
- Dosing interval: monthly oral chew; dogs/puppies 8 weeks+ and ≥4 lb
- Onset: fleas within hours; ticks killed after biting, well within the 24–48 h Lyme transmission window
- Monitoring windows that matter: first 24–72 hours post-dose (adverse reactions); every month (adherence)
- Counsel clients on: isoxazoline-class neurologic signs (tremors, ataxia, seizures); mild GI upset / itching / lethargy; that ticks aren’t repelled on contact
Plain answer for owners who landed here: Serious side effects from NexGard are uncommon. The most common are mild — vomiting, diarrhea, reduced appetite, itching, or tiredness. Rare neurological effects such as tremors or seizures are possible; if you see those, contact your vet. NexGard is given once a month.
What it’s used for — and why clients call about it
NexGard (afoxolaner) is a monthly beef-flavoured chew that kills fleas and ticks in dogs and is indicated to prevent Lyme disease by killing black-legged ticks before they transmit infection. It’s in the isoxazoline class alongside Bravecto, Simparica, and Credelio. Because it’s monthly, the follow-up burden it creates is different from a 12-week product: the questions clients call about (“is this normal,” “should I still see ticks”) cluster early, but the real, recurring risk is the monthly dose that gets skipped — a gap the clinic usually only discovers after a problem.
The adverse-event and monitoring profile
Per the FDA-approved labeling (Boehringer Ingelheim), the reported effects include vomiting, diarrhea, reduced appetite, itching, and lethargy — generally mild and short-lived, and most dogs tolerate the chew well.
As with the whole class, the signal to standardize counseling around is neurological. The FDA’s September 2018 alert noted that NexGard and other isoxazolines have been associated with muscle tremors, ataxia, and seizures in some dogs, including those with no prior history. The class remains FDA-considered safe and effective for most patients; the practical step is screening for seizure/neurologic history at prescribing and giving owners a clear list of signs that warrant a callback. (Sources: FDA Animal Drug Safety Communication, Sept 2018; NexGard FDA label via DailyMed.)
The follow-up window that matters
Adverse reactions, when they occur, show up in the first 24–72 hours — one early check-in catches almost all of them. After that, the recurring risk is monthly adherence: every skipped dose reopens flea, tick, and Lyme exposure. Unlike a 12-week product, NexGard depends on the owner repeating the action twelve times a year, so adherence — not the drug — is usually what determines whether the patient stays protected.
What to ask clients at follow-up
A tight post-prescription check covers four things:
- Did your dog tolerate the chew — any vomiting, soft stool, or low energy?
- Any trembling, stumbling, twitching, or seizure activity? (the neurologic screen)
- Are you still finding ticks or fleas? (expected briefly; flags concerns if persistent)
- Is your monthly dose reminder set?
These four questions are the structured outcome data the clinic wants back in the record — and the monthly reminder is the single highest-leverage thing you can automate for a product like this.
Where compliance breaks down
Monthly preventatives fail on the calendar, not on the chemistry. Doses get skipped over a busy month, a missed reminder becomes two, and protection lapses without anyone noticing until a tick or a flea infestation brings the dog back. The clinic that surfaces the missed dose proactively keeps the patient protected and keeps the recurring script on the books.
Standardizing this follow-up without adding staff time
This is exactly what Nidana Loop automates. After a NexGard prescription, Loop calls or texts the owner in the first few days to confirm there were no adverse reactions, records the responses as a structured note back to the clinic, and flags anything neurologic or tolerance-related for a vet. It then carries the monthly adherence nudge — converting the product’s core weakness (a skipped monthly dose) into a scheduled, hands-off touchpoint that keeps dogs protected and scripts active.
See Loop handle medication follow-up
Loop runs your post-prescription follow-up and monthly adherence reminders automatically, and returns structured outcomes to the clinic. Book a 20-minute demo → · See how Loop works →
For pet owners
How often is NexGard given? Once a month, every month, by mouth.
Does NexGard prevent Lyme disease? Yes — indirectly, by killing the black-legged ticks that carry it before they transmit infection.
Will I still see ticks on my dog? You might, briefly — ticks must bite to take in the medication, so they aren’t repelled on contact.
My dog has a seizure history — is it safe? Talk to your vet first; isoxazolines are used with caution in dogs with seizure or neurologic history.
This article is general information, not veterinary advice. Owners should consult their veterinarian and follow the product’s FDA-approved label.
Sources: FDA Animal Drug Safety Communication and Isoxazoline Fact Sheet (2018); NexGard and NexGard Plus FDA-approved product labeling (Boehringer Ingelheim) via DailyMed; VCA Animal Hospitals; PetMD; GoodRx pet health.